JPS5927895A - 新規なチエノ〔３，２−ｃ〕ピリジン誘導体、その製法および治療用剤 - Google Patents

新規なチエノ〔３，２−ｃ〕ピリジン誘導体、その製法および治療用剤

Info

Publication number
JPS5927895A
JPS5927895A JP58127519A JP12751983A JPS5927895A JP S5927895 A JPS5927895 A JP S5927895A JP 58127519 A JP58127519 A JP 58127519A JP 12751983 A JP12751983 A JP 12751983A JP S5927895 A JPS5927895 A JP S5927895A
Authority
JP
Japan
Prior art keywords
formula
group
atom
acid
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58127519A
Other languages
English (en)
Japanese (ja)
Other versions
JPS64955B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
ダニエル・オ−ベル
クロ−ド・フエラン
ジヤン−ピエ−ル・マフラン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPS5927895A publication Critical patent/JPS5927895A/ja
Publication of JPS64955B2 publication Critical patent/JPS64955B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
JP58127519A 1982-07-13 1983-07-13 新規なチエノ〔３，２−ｃ〕ピリジン誘導体、その製法および治療用剤 Granted JPS5927895A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8212599 1982-07-13
FR8212599A FR2530247B1 (fr) 1982-07-13 1982-07-13 Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique

Publications (2)

Publication Number Publication Date
JPS5927895A true JPS5927895A (ja) 1984-02-14
JPS64955B2 JPS64955B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-01-10

Family

ID=9276096

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58127519A Granted JPS5927895A (ja) 1982-07-13 1983-07-13 新規なチエノ〔３，２−ｃ〕ピリジン誘導体、その製法および治療用剤

Country Status (33)

Country Link
US (1) US4529596A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0099802B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5927895A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR870001270B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE25384T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU554358B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1194875A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS246062B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD211351A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3369683D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK157552C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DZ (1) DZ558A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG16540A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8403901A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI73218C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2530247B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR79592B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU187111B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE55895B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL69049A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA19843A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9203264A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO159725C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ204874A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07491A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH19375A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL142272B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT77018B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG95287G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1272994A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA7142A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (2) YU44384B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA834705B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529462A (ja) * 1998-11-09 2002-09-10 サノフイ−サンテラボ ラセミ化方法
JP2009137989A (ja) * 1997-10-06 2009-06-25 Sanofi-Aventis ヒドロキシ酢酸エステル誘導体、その製法及び合成中間体としての用途
EP2168969A2 (en) 2002-08-02 2010-03-31 Teva Pharmaceutical Industries Ltd. Racemization and Enantiomer Separation of Clopidogrel
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
JP2016041751A (ja) * 2010-10-18 2016-03-31 セレニス セラピューティクス ホールディング エスアー コレステロールモビリゼーションに有用な化合物、組成物及び方法

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8429087D0 (en) * 1984-11-16 1984-12-27 Scras Thienopyridine derivatives
FR2576901B1 (fr) * 1985-01-31 1987-03-20 Sanofi Sa Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
FR2596392B1 (fr) * 1986-03-27 1988-08-05 Sanofi Sa Derives de l'acide a-(hydroxy-3 oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenylacetique, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2597102B1 (fr) * 1986-04-14 1988-08-26 Sanofi Sa Derives de l'acide a-(hydroxy-7 tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
FR2612929B1 (fr) * 1987-02-17 1990-02-09 Sanofi Sa Enantiomere dextrogyre de 1a-(tetrahydro- 4,5,6,7 thieno (3,2-c) pyridyl-5) (chloro-2 phenyl)-acetate de methyle, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5189170A (en) * 1989-09-29 1993-02-23 Sanofi Process for the preparation of phenylacetic derivatives of thieno-pyridines
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
FR2672801B1 (fr) * 1991-02-14 1995-03-03 Sanofi Sa Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
NZ334389A (en) * 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
HU225503B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
HU225504B1 (en) 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU222283B1 (hu) * 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
CA2322171C (en) 1998-02-27 2009-10-27 Sankyo Company Limited Cyclic amino compounds
JP4588877B2 (ja) 1998-06-17 2010-12-01 ブリストル−マイヤーズ スクイブ カンパニー Ａｄｐ−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防
AU2002217464B2 (en) * 2000-12-25 2004-12-16 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
IN191030B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2001-01-24 2003-09-13 Cadila Healthcare Ltd
BR0207064A (pt) * 2001-01-24 2004-03-30 Cadila Healthcare Ltd Processo para a preparação de um composto
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
CA2352520C (en) * 2001-07-06 2007-10-02 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
WO2004031143A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
ITMI20022228A1 (it) * 2002-10-21 2004-04-22 Dinamite Dipharma S P A Sali di clopidogrel con acidi alchil-solforici.
EP1606231A1 (en) * 2003-02-03 2005-12-21 Nadkarni, Sunil Sadanand Process for preparation of clopidogrel, its salts and pharmaceutical compositions
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
US6858734B2 (en) 2003-04-23 2005-02-22 Rhodia Pharma Solutions Inc. Preparation of (S)-Clopidogrel and related compounds
EP1927595B1 (en) * 2003-04-25 2013-03-06 Cadila Healthcare Limited Salts of clopidogrel and process for preparation
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1680430B1 (en) 2003-11-03 2010-01-20 Cadila Healthcare Ltd. Processes for preparing form i of (s)-(+)- clopidogrel bisulfate
CA2454015C (en) * 2003-12-23 2009-11-24 Brantford Chemicals Inc. A process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
WO2005117866A1 (en) * 2004-06-01 2005-12-15 Ivax Pharmaceuticals S.R.O. Amorphous clopidogrel hydrochloride and its antithrombotic use
AR050631A1 (es) * 2004-09-09 2006-11-08 Novartis Ag Combinacion de compuestos organicos
KR20070052780A (ko) * 2004-09-21 2007-05-22 테바 파마슈티컬 인더스트리즈 리미티드 결정질 클로피도그렐 브롬산염 및 이의 제조 방법
US20060223845A1 (en) * 2005-02-24 2006-10-05 Eran Turgeman Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
CZ299213B6 (cs) 2005-03-08 2008-05-21 Zentiva, A. S Zpusob racemizace R(-) izomeru methylesteru kyseliny (2-chlorfenyl)-6,7-dihydro-thieno[3,2-c]pyridin-5(4H)-octové
WO2006130852A1 (en) * 2005-06-02 2006-12-07 Dr. Reddy's Laboratories Ltd. Recovery of clopidogrel bisulfate
EP1902058A2 (en) * 2005-07-12 2008-03-26 RPG Life Sciences Limited A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
WO2007029080A1 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Preparation of form i of clopidogrel hydrochloride
WO2007052300A2 (en) * 2005-09-05 2007-05-10 Cadila Healthcare Limited Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
WO2007029096A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Novel polymorphic forms of clopidogrel hydrochloride
CN100390180C (zh) * 2005-12-15 2008-05-28 上海应用技术学院 氯吡格雷及其盐的制备方法
KR101235117B1 (ko) * 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR100742134B1 (ko) * 2006-02-07 2007-07-24 경동제약 주식회사 결정성Ｓ-(+)-메틸-2-(2-클로로페닐)-2-(6,7-디히드로티에노[3,2-ｃ]피리딘-5(4Ｈ)-일)아세테이트·캄실레이트를 포함하는약학적 조성물
EP2007362B1 (en) 2006-04-04 2018-09-05 KG Acquisition LLC Oral dosage forms including an antiplatelet agent and an acid inhibitor
RU2008146758A (ru) * 2006-04-27 2010-06-10 Инд-Свифт Лэборетриз Лимитед (In) Способ получения полиморфных форм клопидогрела гидросульфата
US8247558B2 (en) * 2006-09-04 2012-08-21 Ranbaxy Laboratories Limited Process for the preparation of clopidogrel and its pharmaceutically acceptable salts
EP1900358A1 (en) 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
KR20090086903A (ko) * 2007-04-18 2009-08-14 테바 파마슈티컬 인더스트리즈 리미티드 개선된 클로피도그렐의 제조 방법
RU2470636C2 (ru) 2007-04-27 2012-12-27 Сайдекс Фамэсьютиклз, Инк. Композиция клопидогреля и сульфоалкилового эфира циклодекстрина (варианты) и способы лечения заболеваний посредством названной композиции (варианты)
US7985859B2 (en) * 2007-05-30 2011-07-26 Wockhardt Ltd. Processes for the preparation of clopidogrel
WO2009080469A1 (en) * 2007-12-24 2009-07-02 Sandoz Ag Process for the preparation of clopidogrel bisulphate form i
PT2095815E (pt) 2008-02-26 2012-02-03 Lesvi Laboratorios Sl Formulações farmacêuticas contendo clopidogrel
CN101983056A (zh) * 2008-04-01 2011-03-02 安斯泰来制药有限公司 血管性疾病的预防剂和/或治疗剂
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
US20130303477A1 (en) * 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
US8759316B2 (en) * 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20120141468A1 (en) * 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
KR100990949B1 (ko) * 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
US8299097B2 (en) * 2008-09-12 2012-10-30 The Brigham And Women's Hospital, Inc. Methods for treating inflammatory disorders
WO2010046476A1 (en) * 2008-10-24 2010-04-29 Sandoz Ag A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101402641B (zh) * 2008-11-20 2011-05-04 天津药物研究院 含噻吩并吡啶的肟类衍生物、其制备方法和用途
EP2416799B1 (en) 2009-04-10 2017-11-01 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
WO2010132711A1 (en) 2009-05-13 2010-11-18 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
KR20120050437A (ko) 2009-06-25 2012-05-18 테트라, 시아 신규한 아세틸살리실산 염들
CN101585842B (zh) * 2009-07-13 2011-07-20 北京赛科药业有限责任公司 氯吡格雷中杂质b的研究及控制方法
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
CA2778880C (en) 2009-11-11 2018-02-13 The Medicines Company Methods of treating or preventing stent thrombosis
WO2011101865A2 (en) 2010-02-19 2011-08-25 Cadila Healthcare Limited Stable pharmaceutical compositions of clopidogrel for parenteral delivery
CN102212069A (zh) * 2010-04-06 2011-10-12 刘桂坤 环烷衍生物及其制备方法和在心脑血管病药物上的应用
CN101812071A (zh) * 2010-05-10 2010-08-25 杭州和素化学技术有限公司 硫酸氢氯吡格雷中间体拆分后的母液处理方法
CN102241690B (zh) 2010-05-13 2015-08-12 天津药物研究院 一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途
CN101863901B (zh) * 2010-06-29 2012-12-05 天津药物研究院 2-(取代苯基)-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5(4H)-基)-N-取代-乙酰胺、其制备方法和用途
WO2012007019A1 (en) 2010-07-13 2012-01-19 Pharmathen S.A. Process for the preparation of clopidogrel and salts thereof
EP2613783B1 (en) 2010-08-26 2019-06-12 IPCA Laboratories Limited Methods for the treatment or prophylaxis of thrombosis or embolism
CN101974015B (zh) * 2010-10-11 2012-05-09 天津药物研究院 酯类化合物、其制备方法和用途
CN101974016A (zh) * 2010-10-14 2011-02-16 天津药物研究院 酰胺类化合物及其制备方法和用途
CN101962388B (zh) * 2010-10-14 2012-12-19 天津药物研究院 乙酰胺衍生物及其制备方法和用途
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN104245707A (zh) 2011-06-27 2014-12-24 Ipca实验室有限公司 抗血栓化合物
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
AU2012349771A1 (en) 2011-12-09 2014-07-03 Wockhardt Limited Methods for treating cardiovascular disorder
CN103665042B (zh) * 2012-09-21 2016-03-16 北京普禄德医药科技有限公司 光学活性的2-羟基四氢噻吩并吡啶衍生物及其制备方法和用途
CN102993210A (zh) * 2012-12-19 2013-03-27 苏春华 一种吡啶并噻吩的新化合物
WO2014118802A1 (en) 2013-01-31 2014-08-07 Pharmazell Gmbh An improved process for the preparation of clopidogrel bisulfate form-i
CN104447867B (zh) * 2013-09-17 2017-12-26 江苏天士力帝益药业有限公司 一种噻吩并哌啶衍生物、制备方法及其应用
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
MX2019015448A (es) 2017-06-23 2020-02-19 Chiesi Farm Spa Metodo para la prevencion de trombosis de desviacion de la arteria sistemica a pulmonar.
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
WO2023012479A1 (en) 2021-08-03 2023-02-09 Liqmeds Worldwide Limited An oral pharmaceutical solution of clopidogrel
CN115260086A (zh) * 2022-09-28 2022-11-01 吉林大学 一种氟代内标物及其应用和制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2527574A (en) * 1948-06-01 1950-10-31 Parke Davis & Co Esters of phenyl-heterocyclicaminoacetic acid and their production
FR1312412A (fr) * 1959-12-18 1962-12-21 Dausse Lab Dérivés de l'acide alpha-phényl alpha-pipéridino acétique et leur préparation
FR2215948B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009137989A (ja) * 1997-10-06 2009-06-25 Sanofi-Aventis ヒドロキシ酢酸エステル誘導体、その製法及び合成中間体としての用途
JP2002529462A (ja) * 1998-11-09 2002-09-10 サノフイ−サンテラボ ラセミ化方法
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
EP2168969A2 (en) 2002-08-02 2010-03-31 Teva Pharmaceutical Industries Ltd. Racemization and Enantiomer Separation of Clopidogrel
JP2016041751A (ja) * 2010-10-18 2016-03-31 セレニス セラピューティクス ホールディング エスアー コレステロールモビリゼーションに有用な化合物、組成物及び方法

Also Published As

Publication number Publication date
NO159725C (no) 1989-02-01
SG95287G (en) 1990-11-23
PT77018B (fr) 1986-01-24
IE831604L (en) 1984-01-13
PH19375A (en) 1986-04-02
DK157552C (da) 1990-06-11
IL69049A0 (en) 1983-10-31
DK304183A (da) 1984-01-14
ZA834705B (en) 1984-03-28
FR2530247A1 (fr) 1984-01-20
MA19843A1 (fr) 1984-04-01
NO832530L (no) 1984-01-16
PT77018A (fr) 1983-08-01
DK304183D0 (da) 1983-07-01
FI73218B (fi) 1987-05-29
JPS64955B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-01-10
FI832543A0 (fi) 1983-07-12
DK157552B (da) 1990-01-22
PL242965A1 (en) 1984-07-16
YU197485A (en) 1986-10-31
NZ204874A (en) 1986-01-24
NO159725B (no) 1988-10-24
HU187111B (en) 1985-11-28
DE3369683D1 (en) 1987-03-12
FI832543L (fi) 1984-01-14
ES523943A0 (es) 1984-04-01
FR2530247B1 (fr) 1986-05-16
OA07491A (fr) 1985-03-31
US4529596A (en) 1985-07-16
EP0099802A1 (fr) 1984-02-01
CS528183A2 (en) 1985-12-16
CA1194875A (fr) 1985-10-08
AU1663783A (en) 1984-01-19
DD211351A5 (de) 1984-07-11
GR79592B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-10-31
KR840005448A (ko) 1984-11-12
UA7142A1 (uk) 1995-06-30
EG16540A (en) 1990-12-30
PL142272B1 (en) 1987-10-31
IL69049A (en) 1986-03-31
KR870001270B1 (ko) 1987-06-30
FI73218C (fi) 1987-09-10
YU150683A (en) 1986-04-30
SU1272994A3 (ru) 1986-11-23
MX9203264A (es) 1992-07-01
YU44384B (en) 1990-06-30
IE55895B1 (en) 1991-02-14
DZ558A1 (fr) 2004-09-13
CS246062B2 (en) 1986-10-16
AU554358B2 (en) 1986-08-21
ATE25384T1 (de) 1987-02-15
ES8403901A1 (es) 1984-04-01
YU45291B (en) 1992-05-28
EP0099802B1 (fr) 1987-02-04

Similar Documents

Publication Publication Date Title
JPS5927895A (ja) 新規なチエノ〔３，２−ｃ〕ピリジン誘導体、その製法および治療用剤
US5416066A (en) 1,4-benzothiazepine derivatives
TW234717B (en) 1-[2-(arylsulfonylamine)-1-oxoethyl]piperidine derivatives, their preparation and therapeutic applications
JPH0645622B2 (ja) 右旋性α−５−（４，５，６，７−テトラヒドロ［３，２−ｃチエノピリジル）−（２−クロロフェニル）酢酸メチル、その製法および医薬
HK2189A (en) Novel pharmaceutical compositions
HU179734B (en) Process for producing pharmaceutically effective new n-2 above-bracket-1,2,3,4-tetrahydro-8-quinolyl-bracket closed-sulfonyl-l-arginine-amides
ZA200505492B (en) 2-Aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
JPH09505036A (ja) 喘息治療用のニューロキニン２受容体拮抗薬としての新規な４−ピペリジニル置換ラクタム
AU688756B2 (en) Novel compound with platelet aggregation inhibitor activity
JPS59152366A (ja) 新規ニトロ脂肪族化合物、その製造法およびその用途
PT91783B (pt) Processo para a preparacao de {(diarilmetoxi) alquil}-1-pirrolidinas e piperidinas
CA1322074C (en) Pharmaceutically useful derivatives of thiazolidine-4- carboxylic acid
JPS62289578A (ja) １，４−ジヒドロピリジン化合物
JPS597192A (ja) ５，６，７，７ａ−テトラヒドロ−４Ｈ−チエノ（３，２−ｃ）ピリジン−２−オン誘導体、その製法および血小板凝集抑制剤
JPS60218377A (ja) ４−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
HUT56340A (en) Process for producing tetrahydronaphthalene derivatives and pharmaceutical compositions comprising such compounds
JPH06500791A (ja) 化合物
JPH0215067A (ja) イソキノリンスルホンアミド誘導体
FR2528431A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
CA2031764A1 (en) Naphthylsulfonylalkanoic acid compounds
CA1324605C (fr) Derives de la 1-arylsulfonyl 2-pyrrolidinone, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
EP0007648B1 (en) New acylureas with pharmaceutical activity, the process for their preparation, and pharmaceutical compositions which contain them
IE44177B1 (en) Sulfides,sulfoxides and sulfones
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
JP2774836B2 (ja) チオフェン誘導体，及び該化合物を含有する医薬組成物